Thyroid Dysfunction in COVID-19 Patients: A Study at Imam Reza Hospital, Sirjan
| Author | Mostafa Kashani | en |
| Author | Sedigheh Barzekar | en |
| Author | Mohammad Hossein Gozashti | en |
| Orcid | Mostafa Kashani [0000-0003-0326-6894] | en |
| Orcid | Sedigheh Barzekar [0000-0002-9447-886X] | en |
| Orcid | Mohammad Hossein Gozashti [0000-0002-2131-3423] | en |
| Issued Date | 2025-10-31 | en |
| Abstract | Background: SARS-CoV-2 affects multiple organ systems, including the thyroid gland, but the mechanisms and clinical impact remain incompletely understood. Objectives: The present study aimed to determine the prevalence and patterns of thyroid dysfunction and its association with inflammation in hospitalized COVID-19 patients. Methods: In this retrospective cohort study conducted between March and September 2021 at Imam Reza Hospital, Sirjan, Kerman province, Iran, we enrolled 167 consecutive adult COVID-19 patients. The sample size provided > 80% power to detect a 15% difference in thyroid stimulating hormone (TSH) abnormalities (α = 0.05). Thyroid hormones [total triiodothyronine (TT3), TSH, total thyroxine (TT4)] were measured by ELISA and C-reactive protein (CRP) on admission. Continuous variables are expressed as mean ± standard deviation (SD) or median (IQR); categorical variables as counts (%). Group comparisons used Kruskal-Wallis and Wilcoxon rank-sum tests; Spearman’s rank correlation assessed associations. Results: Overall, 36.5% of patients exhibited thyroid abnormalities: Low TSH (17.96%), high TSH (5.4%), low TT3 (1.8%), high TT3 (1.8%), low TT4 (6.0%), and high TT4 (3.6%). Disease severity correlated significantly with TSH and TT3 (P < 0.05), and TT4 differed by gender (P = 0.0249). The CRP correlated with disease severity (P = 0.003) and with thyroid markers [TSH rank correlation coefficient (rho) = -0.205, TT4 rho = -0.083, TT3 rho = -0.178]. Conclusions: COVID-19 is associated with a non-thyroidal illness syndrome (NTIS) pattern, notably reduced TSH and TT3 in severe cases while TT4 remains stable. Limitations include single-center design, absence of non-COVID controls, lack of free thyroxine (FT4) measurement, and no post-discharge follow-up. We recommend routine thyroid monitoring in hospitalized COVID-19 patients. | en |
| DOI | https://doi.org/10.5812/archcid-158902 | en |
| Keyword | COVID‑19 | en |
| Keyword | Thyroid Dysfunction | en |
| Keyword | Non‑thyroidal Illness Syndrome | en |
| Keyword | Retrospective Cohort | en |
| Keyword | TT3 | en |
| Keyword | TSH | en |
| Keyword | TT4 | en |
| Keyword | CRP | en |
| Publisher | Brieflands | en |
| Title | Thyroid Dysfunction in COVID-19 Patients: A Study at Imam Reza Hospital, Sirjan | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- archcid-20-5-158902-publish-pdf.pdf
- Size:
- 207.28 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF